Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
- Conditions
- HIV Infections
- Interventions
- Biological: VRC-HIVDNA-016-00-VPBiological: VRCHIVADV014-00-VP
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2021-10-14
- Target Recruit Count
- 17
- Registration Number
- NCT00955006
- Locations
- 🇺🇸
Seattle Vaccine and Prevention CRS, Seattle, Washington, United States
Live Kidney Donor Study - Cross-Sectional and Historical Cohort Study
- Conditions
- End Stage Renal DiseaseTransplantation
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2017-03-14
- Target Recruit Count
- 7029
- Registration Number
- NCT00951977
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Immune Development in Pediatric Transplantation (IMPACT)
- Conditions
- Chronic Kidney FailureEnd Stage Renal Disease
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2019-01-03
- Target Recruit Count
- 125
- Registration Number
- NCT00951353
- Locations
- 🇺🇸
University of California at Los Angeles/ Mattel Children's Hospital, Los Angeles, California, United States
🇺🇸Stanford University Medical Center/ Lucille Packard Children's Hospital, Palo Alto, California, United States
🇺🇸Emory University/ Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)
- Conditions
- Primary Progressive Multiple Sclerosis
- Interventions
- Other: placebo
- First Posted Date
- 2009-07-31
- Last Posted Date
- 2019-03-19
- Target Recruit Count
- 85
- Registration Number
- NCT00950248
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Sanofi H1N1 + TIV - Adults and Elderly
- Conditions
- Influenza
- Interventions
- Biological: Trivalent inactivated influenza vaccineBiological: Inactivated H1N1 VaccineDrug: Placebo
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2012-08-01
- Target Recruit Count
- 805
- Registration Number
- NCT00943878
- Locations
- 🇺🇸
Saint Louis University Hospital - Internal Medicine - Infectious Diseases, Allergy & Immunology, St. Louis, Missouri, United States
🇺🇸Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
- Conditions
- Influenza
- Interventions
- Biological: Inactivated H1N1 Vaccine
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2012-10-31
- Target Recruit Count
- 406
- Registration Number
- NCT00943631
- Locations
- 🇺🇸
Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States
🇺🇸University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States
🇺🇸Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States
CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
- Conditions
- Influenza
- Interventions
- Biological: Inactivated H1N1 Vaccine
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2012-10-31
- Target Recruit Count
- 408
- Registration Number
- NCT00943488
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸Group Health Cooperative, Seattle, Washington, United States
🇺🇸Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
Sanofi Pasteur, TIV + H1N1, Pediatric Population
- Conditions
- Influenza
- Interventions
- Biological: Inactivated H1N1 VaccineBiological: Trivalent Inactivated Influenza Vaccine
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2013-04-22
- Target Recruit Count
- 531
- Registration Number
- NCT00943202
- Locations
- 🇺🇸
Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States
Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels
- Conditions
- Influenza
- Interventions
- Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2015-02-18
- Target Recruit Count
- 583
- Registration Number
- NCT00944073
- Locations
- 🇺🇸
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States
🇺🇸Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States
🇺🇸University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston, Galveston, Texas, United States
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
- Conditions
- Systemic Capillary Leak Syndrome
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2024-10-30
- Target Recruit Count
- 152
- Registration Number
- NCT00936325
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States